DGKA and anti-neutrophil cytoplasmic antibody-associated vasculitis: The finding that stopping PA production by inhibiting DGKα impairs both integrin recycling and secretion suggests that DGKα may represent a viable drug target to reduce tissue injury associated with ANCA-associated vasculitis and other autoimmune disorders where neutrophils play a major role [91].